Pharmacokinetics
Overview:
- AAALAC and OLAW accredited animal facilities with access to broad ranges of animal species
- State of the art instruments
- Extensive experiences in PK model development with comprehensive in vivo technique such as surgical operation and animal care
- Formulation support for in vivo studies including formulation screen, development and formulation recommendation for various species and strains
- PK/PD data analysis, modeling, and simulation
- Regulatory filing support
Animal species
- Mouse, rat, Guinea pig, gerbil, hamster, rabbit, ferret, dog, monkey and mini pig
Dose Route
- IV, PO, SC, IP, IM, IV infusion, SC infusion, intranasal (IN) and intracerebral ventricular (ICV), rectal, topical administration etc.
Sampling
- Tail vein, foot dorsal vein, femoral vein, facial vein, submandibular, CSF (cisternae; spinal cord), tear, lymph, all tissues etc.
Comprehensive Surgery Techniques
- Portal vein cannulation
- Mesenteric lymph duct cannulation
- Bile duct cannulation (rat, dog, and monkey)
- Intraduodenal administration
- Terminal CSF collection (mice) and survival CSF collection ( rat, mini pigs, dog, and monkey)
Biological matrix
- Blood, plasma, urine, tissue, CSF, brain, sciatic nerve, DRG, lymph node, bone marrow and all other tissues.
Formulation development
- Clear solution strategy for IV dosing
- Suspension formulation strategy for chronic toxicity study
- Simulated intestinal fluid (SIF) and simulated gastric fluid (SGF) dilution study for in vivo precipitation and super-saturation prediction
- Advanced formulation approach (microsuspension, nanosuspension or solid dispersion)